| |  Online-Ressource |
|---|
| Verfasst von: | Chen, Xin [VerfasserIn]  |
|---|
| | Chen, Xinyang [VerfasserIn] |
|---|
| | Steimbach, Raphael R. [VerfasserIn] |
|---|
| | Wu, Tong [VerfasserIn] |
|---|
| | Li, Hongmei [VerfasserIn] |
|---|
| | Dan, Wenjia [VerfasserIn] |
|---|
| | Shi, Peidong [VerfasserIn] |
|---|
| | Cao, Chenyu [VerfasserIn] |
|---|
| | Li, Ding [VerfasserIn] |
|---|
| | Miller, Aubry K. [VerfasserIn] |
|---|
| | Qiu, Zhixia [VerfasserIn] |
|---|
| | Gao, Jinming [VerfasserIn] |
|---|
| | Zhu, Yong [VerfasserIn] |
|---|
| Titel: | Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors |
|---|
| Titelzusatz: | rational design, synthesis and antiproliferative activity |
|---|
| Verf.angabe: | Xin Chen, Xinyang Chen, Raphael R. Steimbach, Tong Wu, Hongmei Li, Wenjia Dan, Peidong Shi, Chenyu Cao, Ding Li, Aubry K. Miller, Zhixia Qiu, Jinming Gao, Yong Zhu |
|---|
| E-Jahr: | 2020 |
|---|
| Jahr: | 1 February 2020 |
|---|
| Umfang: | 13 S. |
|---|
| Fussnoten: | Gesehen am 10.07.2024 |
|---|
| Titel Quelle: | Enthalten in: European journal of medicinal chemistry |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1987 |
|---|
| Jahr Quelle: | 2020 |
|---|
| Band/Heft Quelle: | 187(2020), Artikel-ID 111950, Seite 1-13 |
|---|
| ISSN Quelle: | 1768-3254 |
|---|
| Abstract: | Histone deacetylase 6 (HDAC6) has gained popular attention for its wide participation in various pathological process recently. In this paper, a series of novel derivatives containing 2, 5-diketopiperazine (DKP) skeleton were developed as potent selective HDAC6 inhibitors (sHDAC6is). Most of these compounds exhibited low nanomolar IC50 values toward HDAC6, and the best compound was 21b (IC50 = 0.73 nM) which had 144-10941-fold selectivity over other HDAC isoforms. Western blot assay further validated these compounds to be sHDAC6is. Molecular simulation of 21b was conducted to rationalize the high binding affinity for HDAC6. In the cytotoxicity experiment, 18a, 18b and 18d gave superior or comparable influence on the growth of two multiple myeloma cells U266 and RPMI-8226 compared to ACY-1215. Moreover, the combination of 18a and adriamycin showed synergistic effect against non-small cell lung cancer cell A549. 18a and 18b also demonstrated appropriate drug metabolism in human liver microsome (HLM). |
|---|
| DOI: | doi:10.1016/j.ejmech.2019.111950 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1016/j.ejmech.2019.111950 |
|---|
| | Volltext: https://www.sciencedirect.com/science/article/pii/S022352341931102X |
|---|
| | DOI: https://doi.org/10.1016/j.ejmech.2019.111950 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Combination therapy |
|---|
| | DKP |
|---|
| | HDAC6 inhibitor |
|---|
| | Selectivity |
|---|
| | Synthesis |
|---|
| K10plus-PPN: | 1895011736 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors / Chen, Xin [VerfasserIn]; 1 February 2020 (Online-Ressource)
